Trial Profile

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study, Evaluating the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution in Subjects With Social Anxiety Disorder

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 29 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cannabidiol (Primary)
Indications Social phobia
Focus Registrational; Therapeutic Use
Sponsors EmpowerPharm

Most Recent Events

27 Aug 2024 Status changed from active, no longer recruiting to completed.
06 Jun 2024 According to an EmpowerPharm media release, the results of the Phase 2 study will guide further clinical research and the design of a robust Phase 3 program to advance the treatment of Social Anxiety Disorder
06 Jun 2024 Results published in the EmpowerPharm Inc. Media Release

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com